0N6A vs NNNN: Side-by-Side Comparison
Compare TME PHARM.CONF.IPO EO 1- (0N6A) and Anbio Biotechnology - Class A (NNNN) side by side: market cap EUR 5.91M vs USD 557.42M. Financials, growth and model signals on Bullrun.
| Metric | 0N6A | NNNN |
|---|---|---|
| Company | TME PHARM.CONF.IPO EO 1- | Anbio Biotechnology - Class A |
| Country / Exchange | Germany · F | Germany · NASDAQ |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Medical Instruments & Supplies |
| Market cap | EUR 5.91M | USD 557.42M |
| P/E ratio | — | — |
| Dividend yield | — | — |
| Valuation model | — | — |
| Revenue (latest FY) | EUR 0 | USD 8.65M |
| Revenue growth YoY | — | +5.6% |
| Net income | EUR -5.72M | USD 6.40M |
| Gross margin | — | 87.2% |
| Diluted EPS | — | 0.15 |
Figures are in each company's reporting currency — compare growth rates and margins rather than raw amounts.